These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6346845)

  • 21. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
    Cardiac Arrhythmia Pilot Study (CAPS) Investigators
    Am J Cardiol; 1988 Mar; 61(8):501-9. PubMed ID: 2894169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Initial results of clinical research on a tabletted form of ethacizin (the diethylamino analog of ethmozine) in ventricular arrhythmias].
    Rozenshtraukh LV; Shugushev KhKh; Smetnev AS; Mukharliamov NM; Ponomarenko EL
    Kardiologiia; 1985 Mar; 25(3):43-50. PubMed ID: 2582177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of prolonged ethmozine treatment in patients with ventricular arrhythmias].
    Kurbanov RD; Mazur NA
    Kardiologiia; 1983 Nov; 23(11):51-5. PubMed ID: 6197557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethmozine (moricizine HCl): a promising drug for "automatic" atrial ectopic tachycardia.
    Evans VL; Garson A; Smith RT; Moak JP; McVey P; McNamara DG
    Am J Cardiol; 1987 Oct; 60(11):83F-86F. PubMed ID: 3310591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A preliminary report on the antiarrhythmic effect of ethmozine].
    Fang WH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Jun; 16(3):154-5. PubMed ID: 3065022
    [No Abstract]   [Full Text] [Related]  

  • 26. Moricizine: a novel antiarrhythmic agent.
    Carnes CA; Coyle JD
    DICP; 1990; 24(7-8):745-53. PubMed ID: 2197817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of moricizine in malignant ventricular arrhythmias.
    Horowitz LN
    Am J Cardiol; 1990 Feb; 65(8):41D-46D; discussion 68D-71D. PubMed ID: 1689535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine).
    Morganroth J; Pratt CM
    Am J Cardiol; 1989 Jan; 63(3):172-6. PubMed ID: 2642632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia.
    Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME
    Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardia.
    Pratt CM; Francis M; Mahler S; Aogaichi K; Keus P; Young JB
    Am Heart J; 1988 Oct; 116(4):897-903. PubMed ID: 2459950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness and characteristics of the action of etmozin in treating extrasystole in middle-aged and elderly patients].
    Korkushko OV; Butenko AG; Kaukenas IK
    Ter Arkh; 1986; 58(6):65-70. PubMed ID: 2429380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The changing base line of complex ventricular arrhythmias. A new consideration in assessing long-term antiarrhythmic drug therapy.
    Pratt CM; Delclos G; Wierman AM; Mahler SA; Seals AA; Leon CA; Young JB; Quinones MA; Roberts R
    N Engl J Med; 1985 Dec; 313(23):1444-9. PubMed ID: 3903506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-arrhythmic effectiveness of ethmozine, cordaron and rhythmodan in treating ischemic heart disease].
    Zhivoderov VM; Zakharov VN; Doshchitsin VL; Aksenova TN; Andriukova EI
    Kardiologiia; 1981 Sep; 21(9):41-4. PubMed ID: 6171668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative effectiveness of ethmozine, mexitil, quinidine and obsidan in the treatment of ventricular rhythm disorders].
    Kurbanov RD; Mazur NA
    Kardiologiia; 1981 Oct; 21(10):59-64. PubMed ID: 6170776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic drug therapy for suppression of ventricular arrhythmia: experience with 122 patients treated for two years.
    Salerno DM; Fifield J; Hodges M
    J Clin Pharmacol; 1990 Mar; 30(3):226-34. PubMed ID: 2312780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemodynamic effect of ethmozine and its diethylamine analog ethacizin on central hemodynamics in patients with various functional states of the myocardium].
    Ageev FT; Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):113-5. PubMed ID: 3890894
    [No Abstract]   [Full Text] [Related]  

  • 37. Moricizine: pharmacodynamic, pharmacokinetic, and therapeutic profile of a new antiarrhythmic.
    Vanerio G; Maloney JD
    Cleve Clin J Med; 1992; 59(1):79-86. PubMed ID: 1551218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experience in the clinical use of etmozin in different cardiac rhythm disturbances].
    Mazur NA; Liakishev AA; Kubanov RD
    Kardiologiia; 1980 Jul; 20(7):44-9. PubMed ID: 6157047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of the diethylamine analog of etmozin on myocardial function (a clinical and experimental study)].
    Rozenshtraukh LV; Kaverina EP; Aniukhovskiĭ EP; Dremin SA; Beloshapko GG
    Kardiologiia; 1982; 22(6):72-8. PubMed ID: 7120743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cimetidine inhibition of ethmozine metabolism.
    Biollaz J; Shaheen O; Wood AJ
    Clin Pharmacol Ther; 1985 Jun; 37(6):665-8. PubMed ID: 3891190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.